NIH Consensus Development Conference on Lowering Blood Cholesterol to Prevent Heart Disease: Implications for dietitians

Journal of the American Dietetic Association - Tập 85 - Trang 586-588 - 1985
Nancy D. Ernst1
1Division of Epidemiology and Clinical Applications, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland

Tài liệu tham khảo

1984, JAMA, 251, 351, 10.1001/jama.1984.03340270029025 1984, JAMA, 251, 365, 10.1001/jama.1984.03340270043026 Brensiki, 1984, Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: Results of the NHLBI Type II Coronary Intervention Study, Circulation, 69, 313, 10.1161/01.CIR.69.2.313 Canner, P.: Mortality in Coronary Drug Project patients during a nine-year post-treatment period. Summary of the NHLBI Workshop on the Lipid Research Clinics Coronary Primary Prevention Trial. Arteriosclerosis. In press. The Lipid Research Clinics Population Studies Data Book. Vol. 1. The Prevalence Study. DHHS Publ. No. (NIH) 80-1527, 1980. Gotto, 1984, Recommendations for treatment of hyperlipoproteinemia for treatment of hyperlipidemia in adults, Circulation, 69, 1067A